Kanabo Group Plc (LSE:KNB), a medical cannabis R&D Company that focuses on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers, announces Kanabo’s CBD products
Publication shows effectiveness of SFX-01 in patient derived glioblastoma cells University of Auckland data
Open Orphan plc (AIM: ORPH), a rapidly growing specialist clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that hVIVO
MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, notes the recent Government statement regarding measures to simplify international travel.
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF ), one of the UK’s leading CBD and hemp product suppliers , is pleased to announce that it has received its initial
Proposed accounting treatment of ongoing DHSC dispute in 2021 interim results
DeepVerge has announced its unaudited interim results for the six months ended 30 June 2021. Once again delivering on best financial expectations, H1 2021 revenues expanded by 231% to £3.319m
DeepVerge and Ion Exchange announce India Centre of Excellence for Modern Water All Membrane Brine Concentration (“AMBC”)
Biotherapeutic MRx0518 at the European Society for Medical Oncology (ESMO) Congress 2021
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, will hold its Annual General Meeting (‘AGM’) today at 11am at Omega
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a further update on its current
